期刊
JOURNAL OF INFECTIOUS DISEASES
卷 210, 期 1, 页码 65-71出版社
OXFORD UNIV PRESS INC
DOI: 10.1093/infdis/jiu046
关键词
C. trachomatis; trachoma; azithromycin; resistance; mass drug administration
资金
- Bill and Melinda Gates Foundation
Background. Trachoma, caused by repeated infections with ocular Chlamydia trachomatis, is targeted for elimination using multiple annual rounds of mass drug administration (MDA) in endemic communities. Infection rates do not decline as expected in some communities, leading to concerns about azithromycin resistance. Methods. After 3 yearly MDAs in 32 communities in Tanzania, 107 children were identified 1 year later with infection. All were provided MDA again, and 90 were seen again at 2 months, of whom 30 had infection. Chlamydia trachomatis isolates were obtained before and after MDA in 15 paired samples and were tested for antimicrobial susceptibility. The infectious load of C. trachomatis before MDA was determined in 30 children who had infection at both times and 60 whose infection cleared. Results. The median load was 8.6 genome copies per polymerase chain reaction in the consistently infected, and 8.4 in those whose infection cleared (P = .86). For the consistently infected, the average minimum inhibitory concentration was 0.26 mu g/mL for azithromycin before and 0.20 mu g/mL after MDA. All isolates had minimum inhibitory concentration <= 0.50 mu g/mL. Conclusions. There is no evidence that continued infection after MDA was due either to resistance to azithromycin or to a heavier load of organism before treatment. Other potential causes of persistent infection need to be evaluated.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据